Blood Chemistry Monitoring

How it works

Benefits

Dosage & preparation

Risks & contraindications

Comparisons

Highlighted claims

• All interviewed clinicians confirmed that blood chemistry review is a mandatory core component of chemotherapy delivery required by clinical protocol before every treatment cycle. — What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients’ risk of hepatic and renal deterioration during chemotherapy? A qualitative study
• Clinicians value blood chemistry not only for detecting specific risk signals but for the holistic picture of patient health it provides. — What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients’ risk of hepatic and renal deterioration during chemotherapy? A qualitative study
• Delays in receiving blood chemistry results are commonly caused by external laboratory workflows and incompatible data formats that are difficult to integrate into electronic patient record systems. — What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients’ risk of hepatic and renal deterioration during chemotherapy? A qualitative study
• Hospitals relying on external laboratories face formatting incompatibilities, delays chasing results, and workflow disruption, while those with internal or partner-site labs can receive and integrate results quickly via EPR. — What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients’ risk of hepatic and renal deterioration during chemotherapy? A qualitative study
• Standard protocols often require blood chemistry review before each cycle regardless of how low a patient's perceived risk is. — What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients’ risk of hepatic and renal deterioration during chemotherapy? A qualitative study
• The frequency of blood chemistry testing varies depending on which specific drugs are prescribed. — What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients’ risk of hepatic and renal deterioration during chemotherapy? A qualitative study